EVGN short interest
Evogene Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 932,725 |
|---|---|
| Change vs prior report | 875,916 (+1541.9%) |
| Change over six months | +289.8% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 6,278,931 |
| Rank in Healthcare | #779 of 922 by days to cover |
EVGN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 932,725 | +1541.9% | 1.00 | 6,278,931 |
| 2026-09-15 | 56,809 | +7.2% | 1.00 | 294,829 |
| 2026-08-31 | 53,001 | -77.2% | 1.00 | 219,870 |
| 2026-08-14 | 232,078 | +414.3% | 1.00 | 994,693 |
| 2026-07-31 | 45,127 | -81.9% | 1.00 | 210,507 |
| 2026-07-15 | 248,770 | +20.0% | 1.00 | 3,389,168 |
| 2026-06-30 | 207,368 | -33.9% | 1.00 | 3,489,291 |
| 2026-06-15 | 313,620 | +154.6% | 1.00 | 2,420,901 |
| 2026-05-29 | 123,199 | -20.3% | 1.79 | 68,884 |
| 2026-05-15 | 154,554 | -4.5% | 2.97 | 51,998 |
| 2026-04-30 | 161,770 | -4.7% | 3.39 | 47,661 |
| 2026-04-15 | 169,681 | -29.1% | 3.13 | 54,207 |
| 2026-03-31 | 239,261 | -1.2% | 1.44 | 165,668 |
| 2026-03-13 | 242,174 | +28.7% | 1.28 | 188,709 |
| 2026-02-27 | 188,218 | -30.9% | 3.28 | 57,400 |
| 2026-02-13 | 272,348 | +263.7% | 1.00 | 2,291,022 |
| 2026-01-30 | 74,880 | +0.1% | 3.94 | 18,994 |
| 2026-01-15 | 74,833 | +14.0% | 2.25 | 33,305 |
| 2025-12-31 | 65,630 | +32.0% | 1.00 | 78,479 |
| 2025-12-15 | 49,723 | -30.8% | 1.19 | 41,656 |
| 2025-11-28 | 71,799 | -24.8% | 1.34 | 53,755 |
| 2025-11-14 | 95,469 | +46.8% | 2.36 | 40,378 |
| 2025-10-31 | 65,047 | -33.7% | 1.00 | 68,181 |
| 2025-10-15 | 98,150 | +37.6% | 1.00 | 211,275 |
| 2025-09-30 | 71,315 | -23.4% | 1.23 | 57,800 |
import finzdata as yf
yf.Ticker("EVGN").short_interest # every report since 2017
yf.Client().short_interest(["EVGN"], start="2018-01-01")Healthcare short interest · EVGN price history · Who owns EVGN · All short interest